BRAF and Lynch syndrome: Diagnosis should include a serum measurement of carcinoembriyogenic antigen (CEA), mismatch repair or microsatellite instability testing, and evaluation of genetic mutations such as RAS and BRAF, particularly in the context of potential Lynch syndrome [12].